Malaga Cove Capital LLC cut its position in Medidata Solutions, Inc. (NASDAQ:MDSO) by 0.5% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 38,047 shares of the company’s stock after selling 198 shares during the period. Medidata Solutions comprises about 1.8% of Malaga Cove Capital LLC’s portfolio, making the stock its 12th largest position. Malaga Cove Capital LLC’s holdings in Medidata Solutions were worth $2,976,000 as of its most recent filing with the SEC.
Several other institutional investors also recently modified their holdings of MDSO. Acrospire Investment Management LLC bought a new position in shares of Medidata Solutions during the first quarter worth about $121,000. LS Investment Advisors LLC boosted its position in shares of Medidata Solutions by 44.6% in the first quarter. LS Investment Advisors LLC now owns 3,310 shares of the company’s stock worth $191,000 after buying an additional 1,021 shares during the last quarter. World Asset Management Inc bought a new position in shares of Medidata Solutions during the first quarter worth about $201,000. Miles Capital Inc. bought a new position in shares of Medidata Solutions during the first quarter worth about $202,000. Finally, Oppenheimer & Close LLC bought a new position in shares of Medidata Solutions during the first quarter worth about $210,000.
Medidata Solutions, Inc. (NASDAQ:MDSO) traded up 0.15% during midday trading on Friday, reaching $75.89. The company had a trading volume of 160,675 shares. Medidata Solutions, Inc. has a one year low of $46.10 and a one year high of $85.92. The stock’s 50 day moving average is $77.53 and its 200 day moving average is $63.59. The company has a market capitalization of $4.27 billion, a PE ratio of 128.85 and a beta of 1.81.
Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings data on Tuesday, July 18th. The company reported $0.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.03. The business had revenue of $137.41 million for the quarter, compared to analysts’ expectations of $134.28 million. Medidata Solutions had a net margin of 7.07% and a return on equity of 11.14%. The firm’s quarterly revenue was up 19.9% compared to the same quarter last year. During the same period last year, the firm posted $0.24 earnings per share. Equities research analysts forecast that Medidata Solutions, Inc. will post $1.28 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Malaga Cove Capital LLC Sells 198 Shares of Medidata Solutions, Inc. (NASDAQ:MDSO)” was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this story on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be viewed at https://stocknewstimes.com/2017/07/21/malaga-cove-capital-llc-sells-198-shares-of-medidata-solutions-inc-nasdaqmdso.html.
A number of equities analysts recently issued reports on the company. Morgan Stanley lifted their target price on Medidata Solutions from $63.00 to $74.00 and gave the stock an “overweight” rating in a report on Friday, April 28th. Needham & Company LLC lifted their price objective on Medidata Solutions from $65.00 to $75.00 and gave the company a “buy” rating in a research report on Thursday, April 27th. Piper Jaffray Companies lifted their price objective on Medidata Solutions to $87.00 and gave the company an “overweight” rating in a research report on Friday, July 7th. BidaskClub raised Medidata Solutions from a “hold” rating to a “buy” rating in a research report on Wednesday, June 21st. Finally, Zacks Investment Research raised Medidata Solutions from a “hold” rating to a “buy” rating and set a $75.00 price target for the company in a research report on Wednesday, May 3rd. Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Medidata Solutions currently has an average rating of “Buy” and a consensus target price of $76.83.
In other Medidata Solutions news, EVP Michael I. Otner sold 7,500 shares of the business’s stock in a transaction on Monday, May 1st. The shares were sold at an average price of $66.39, for a total transaction of $497,925.00. Following the sale, the executive vice president now owns 78,419 shares of the company’s stock, valued at $5,206,237.41. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Robert Taylor sold 5,639 shares of the business’s stock in a transaction on Monday, June 5th. The stock was sold at an average price of $73.46, for a total transaction of $414,240.94. Following the sale, the director now directly owns 54,372 shares in the company, valued at approximately $3,994,167.12. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 18,139 shares of company stock worth $1,259,466. Insiders own 5.80% of the company’s stock.
Medidata Solutions Company Profile
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions, Inc. (NASDAQ:MDSO).
Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
